Amdocs Stock Forecast, Price & News

Amdocs' stock was trading at $61.42 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, DOX stock has increased by 8.6% and is now trading at $66.73.
View which stocks have been most impacted by COVID-19.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Amdocs in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Amdocs or view MarketBeat's top 5 stock picks.

Wall Street analysts have given Amdocs a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Amdocs wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Amdocs is scheduled to release its next quarterly earnings announcement on Tuesday, February 2nd 2021.
View our earnings forecast for Amdocs.

Amdocs Limited (NASDAQ:DOX) posted its earnings results on Tuesday, November, 10th. The technology company reported $1.23 earnings per share for the quarter, topping the consensus estimate of $1.19 by $0.04. The technology company had revenue of $1.05 billion for the quarter, compared to analyst estimates of $1.03 billion. Amdocs had a net margin of 11.94% and a return on equity of 15.57%. The firm's revenue for the quarter was up 2.2% on a year-over-year basis. During the same period in the prior year, the business earned $1.08 earnings per share.
View Amdocs' earnings history.

Amdocs announced a quarterly dividend on Tuesday, November 10th. Shareholders of record on Thursday, December 31st will be given a dividend of $0.327 per share on Friday, January 22nd. This represents a $1.31 dividend on an annualized basis and a yield of 1.96%. The ex-dividend date is Wednesday, December 30th.
View Amdocs' dividend history.

Amdocs updated its first quarter earnings guidance on Tuesday, November, 10th. The company provided EPS guidance of $1.09-1.15 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.14. The company issued revenue guidance of $1.055-1.095 billion, compared to the consensus revenue estimate of $1.06 billion.

4 equities research analysts have issued 1-year target prices for Amdocs' shares. Their forecasts range from $74.00 to $76.00. On average, they expect Amdocs' stock price to reach $75.00 in the next year. This suggests a possible upside of 12.4% from the stock's current price.
View analysts' price targets for Amdocs.

Amdocs saw a increase in short interest in the month of October. As of October 15th, there was short interest totaling 2,580,000 shares, an increase of 14.7% from the September 30th total of 2,250,000 shares. Based on an average daily volume of 629,800 shares, the short-interest ratio is presently 4.1 days. Currently, 1.9% of the shares of the company are sold short.
View Amdocs' Short Interest.

Some companies that are related to Amdocs include Accenture (ACN), International Business Machines (IBM), Cognizant Technology Solutions (CTSH), EPAM Systems (EPAM), Leidos (LDOS), Gartner (IT), Booz Allen Hamilton (BAH), CACI International (CACI), ManTech International (MANT), Teradata (TDC), Virtusa (VRTU), Unisys (UIS), Forrester Research (FORR), The Hackett Group (HCKT) and ServiceSource International (SREV).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Amdocs investors own include The Home Depot (HD), Pfizer (PFE), AT&T (T), NVIDIA (NVDA), Exxon Mobil (XOM), AbbVie (ABBV), International Business Machines (IBM), Johnson & Johnson (JNJ), Advanced Micro Devices (AMD) and Comcast (CMCSA).

Amdocs trades on the NASDAQ under the ticker symbol "DOX."

Amdocs' stock is owned by a variety of retail and institutional investors. Top institutional investors include LSV Asset Management (4.74%), Wells Fargo & Company MN (4.08%), Massachusetts Financial Services Co. MA (3.82%), BlackRock Inc. (2.86%), Cooke & Bieler LP (1.70%) and Acadian Asset Management LLC (1.63%).

DOX stock was sold by a variety of institutional investors in the last quarter, including Wedge Capital Management L L P NC, Wells Fargo & Company MN, Lord Abbett & CO. LLC, AQR Capital Management LLC, New York State Common Retirement Fund, Arrowstreet Capital Limited Partnership, Acadian Asset Management LLC, and Charles Schwab Investment Management Inc..

DOX stock was purchased by a variety of institutional investors in the last quarter, including LSV Asset Management, Massachusetts Financial Services Co. MA, Truist Financial Corp, First Trust Advisors LP, AXA S.A., Cooke & Bieler LP, Voloridge Investment Management LLC, and Crossmark Global Holdings Inc..

Shares of DOX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of DOX stock can currently be purchased for approximately $66.73.

Amdocs has a market capitalization of $8.99 billion and generates $4.17 billion in revenue each year. The technology company earns $497.84 million in net income (profit) each year or $4.19 on an earnings per share basis. Amdocs employs 26,000 workers across the globe.

The official website for Amdocs is www.amdocs.com.

Amdocs' mailing address is 1390 Timberlake Manor Parkway, Chesterfield MO, 63017. The technology company can be reached via phone at 1 314 212 7000 or via email at [email protected]